STOCKHOLDERS’ DEFICIT (Tables)

12 Months Ended

Dec. 31, 2021

Equity [Abstract]

Schedule of Summary of Warrants

The following is a summary of warrants at December 31, 2021:

STOCKHOLDERS' DEFICIT

	Shares			Exercise Price ($)		Expiration Date
Class R Warrants: (Issued for Private Placement)
Outstanding and exercisable at January 1, 2020		15,000,001			.045	Aug 1 to Dec 9, 2023
Outstanding and exercisable at December 31, 2020		15,000,001
Warrants expired		(3,333,333	)
Outstanding and exercisable at December 31, 2021		11,666,668
Class S Warrants: (Issued for Private Placement of Preferred Stock)
Outstanding and exercisable at January 1, 2020		5,100,000			.03	Dec 30, 2021 to Mar 30, 2022
Warrants exercised		(466,664	)
Outstanding and exercisable at December 31, 2020		4,633,336
Warrants exercised		(4,633,336	)
Outstanding and exercisable at December 31, 2021		-
Class T Warrants: (Issued with Senior Secured Notes Payable)
Outstanding and exercisable at January 1, 2020		22,608,357			.03	Dec 22, 2022 to Oct 31, 2024
Warrants exercised		(5,000,000	)
Outstanding and exercisable at December 31, 2020		17,608,357
Warrants exercised		(6,947,131	)
Outstanding and exercisable at December 31, 2021		10,661,226
Warrants outstanding at December 31, 2020 were 37,241,694 with a weighted average exercise price of $0.036. Warrants outstanding and weighted average exercise price at December 31, 2021		22,327,894			.038

Schedule of Stock Option Transactions

A summary of stock option transactions for the years ended December 31, 2021 and 2020 are as follows:

STOCKHOLDERS' DEFICIT (Details 2)

	Shares			Weighted- Average Exercise Price (per share)		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Options outstanding and exercisable at December 31, 2019		1,075,000		$	0.06		6.24	$	0
Options outstanding and exercisable at December 31, 2020		1,075,000		$	0.06		5.24	$	2,125
Options expired		(25,000	)	$	0.21
Options outstanding and exercisable at December 31, 2021		1,050,000		$	0.05		4.35	$	38,225